This provider's $20.0M in total Medicare payments ranks in the 95th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 173% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 190% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $50.11 | $21.43 | 2.34x | $28.68 | $526.9K | 36.6K | 30.7K |
| 2017 | $54.96 | $21.97 | 2.50x | $32.99 | $1.0M | 69.1K | 53.8K |
| 2018 | $58.20 | $25.74 | 2.26x | $32.46 | $1.3M | 81.6K | 64.1K |
| 2019 | $67.40 | $32.92 | 2.05x | $34.48 | $1.3M | 80.8K | 66.8K |
| 2020 | $79.01 | $36.81 | 2.15x | $42.20 | $3.8M | 94.6K | 76.7K |
| 2021 | $80.05 | $37.81 | 2.12x | $42.24 | $5.8M | 159.1K | 111.0K |
| 2022 | $82.94 | $37.89 | 2.19x | $45.05 | $4.7M | 151.0K | 110.3K |
| 2023 | $75.08 | $31.68 | 2.37x | $43.40 | $1.4M | 86.0K | 71.2K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 108.0K | $8.7M | $80.82 | 1.52x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 74.3K | $1.8M | $24.89 | 1.00x |
| 80053 | Blood test, comprehensive group of blood chemicals | 61.3K | $684.8K | $11.16 | 5.99x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 49.9K | $674.7K | $13.52 | 4.04x |
| 84443 | Blood test, thyroid stimulating hormone (TSH) | 36.6K | $672.0K | $18.34 | 2.74x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 4.5K | $486.7K | $108.95 | 1.13x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 12.6K | $294.5K | $23.30 | 1.07x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 34.3K | $287.7K | $8.39 | 2.58x |
| 80048 | Blood test, basic group of blood chemicals | 29.7K | $261.7K | $8.82 | 5.16x |
| 80307 | Testing for presence of drug | 3.5K | $224.2K | $63.64 | 1.40x |
| 82607 | Cyanocobalamin (vitamin B-12) level | 11.7K | $190.8K | $16.25 | 3.38x |
| 0058U | Measurement of antibodies to Merkel cell polyoma virus oncoprotein in serum | 556 | $177.8K | $319.70 | 1.04x |
| 82306 | Vitamin D-3 level | 5.4K | $165.1K | $30.32 | 1.11x |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 18.8K | $135.3K | $7.22 | 2.66x |
| 0097U | Test for detection of gastrointestinal disease-causing organism using amplified probe | 399 | $135.3K | $338.98 | 1.01x |
| 87507 | Detection test for digestive tract pathogen | 397 | $132.9K | $334.69 | 1.02x |
| 86038 | Screening test for autoimmune disorder | 9.9K | $131.3K | $13.25 | 5.09x |
| G0480 | Drug test def 1-7 classes | 1.3K | $129.1K | $102.16 | 1.18x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 70 | $128.7K | $1.8K | 1.20x |
| 82746 | Folic acid level | 8.1K | $127.9K | $15.88 | 2.52x |
This provider submits charges 2.17 times higher than what Medicare actually pays.
A markup ratio of 2.17x means for every $100 Medicare pays, this provider initially charges $217. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in WA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America | Seattle, WA | $203.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Seattle, WA | $97.9M | ⚠️ Flagged |
| Carenexa, Llc | Vancouver, WA | $70.5M | ✓ Clear |
| Adaptive Biotechnologies Corporation | Seattle, WA | $54.5M | ✓ Clear |
| Regional Toxicology Services, Llc | Tacoma, WA | $37.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data